NEW YORK--(BUSINESS WIRE)--July 7, 2006--INNOVIVE Pharmaceuticals, Inc., a Manhattan-based biopharmaceutical company, announced today that Antony Pfaffle, M.D. and J. Jay Lobell have joined the company’s Board of Directors. “The addition of Dr. Pfaffle and Mr. Lobell to our board both broadens our depth of expertise and positions us to move forward with our goals and objectives,” said Steven Kelly, President and CEO, INNOVIVE Pharmaceuticals, Inc.
